NCT05339945

Brief Summary

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death. As secondary objectives, the study aims:

  • to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them;
  • to study the association between clinical pathway and the indication of targeted palliative care;
  • to study the association between the integration of palliative care service and the adequation of health needs service of patients;
  • to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
361

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 21, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 2, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2024

Completed
Last Updated

December 4, 2024

Status Verified

November 1, 2024

Enrollment Period

1.9 years

First QC Date

April 6, 2022

Last Update Submit

December 3, 2024

Conditions

Keywords

metastatic cancerpalliative careoncologyhealth needsearly integration

Outcome Measures

Primary Outcomes (4)

  • Auto-evaluation

    Evaluation by patient and principal caregiver the health needs. Questionnaires: EORTC-QLQ C30

    at baseline

  • Auto-evaluation

    Evaluation by patient and principal caregiver the health needs. Questionnaires: SCNS-SF34

    at baseline

  • Auto-evaluation

    Evaluation by patient and principal caregiver the health needs. Questionnaires: EPICES

    at baseline

  • Auto-evaluation

    Evaluation by patient and principal caregiver the health needs. Questionnaires: Echelle de Zarit.

    at baseline

Secondary Outcomes (4)

  • Description of disease

    at baseline

  • Clinical trajectory description

    at baseline

  • Proportion (%) of patients needing palliative treatment

    at the end of study

  • Survivor (%)

    at 1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with diagnosed metastatic cancer.

You may qualify if:

  • Patients ≥ 18 years;
  • Diagnosed metastatic cancer;
  • Outpatient or inpatient care at a participating site to the study;
  • Affiliation to the social security scheme;
  • Patient informed and non-opposed to participate to the study.

You may not qualify if:

  • Testicular or choriocarcinoma ovarian cancer;
  • Hematology cancer;
  • No understanding french language;
  • Unable to express if needed his non-opposition opinion, according to physician investigator;
  • Visually impaired, hearing impaired or aphasic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mobile palliative care and support team, Ambroise Paré hospital, APHP

Boulogne-Billancourt, 92100, France

Location

Related Publications (2)

  • Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016 Dec;17(12):e552-e559. doi: 10.1016/S1470-2045(16)30577-0.

    PMID: 27924753BACKGROUND
  • Sahut d'Izarn M, Vinant P, Bouleuc C, Joffin I, Vincent B, Barth C, Serresse L, Codogno A, Behal F, Ya-de Rauglaudre L, Jacota M, Gassama M, de Stampa M. Healthcare needs of patients with metastatic cancer and impacts of social vulnerability: a multicentric cross-sectional study in France. BMC Palliat Care. 2025 Sep 29;24(1):233. doi: 10.1186/s12904-025-01882-4.

MeSH Terms

Conditions

Neoplasm MetastasisNeoplasms

Condition Hierarchy (Ancestors)

Neoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marine SAHUT D'IZARN, MD

    Mobile palliative care and support team, Ambroise Paré hospital, APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 21, 2022

Study Start

June 2, 2022

Primary Completion

May 10, 2024

Study Completion

October 21, 2024

Last Updated

December 4, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations